A

AIM ImmunoTech Inc
AMEX:AIM

Watchlist Manager
AIM ImmunoTech Inc
AMEX:AIM
Watchlist
Price: 1.2732 USD 6.99% Market Closed
Market Cap: 3.6m USD

During the last 3 months AIM ImmunoTech Inc insiders have not bought any shares, and have not sold any shares. The stock price has dropped by 52% over this period (open performance analysis).

The last transaction was made on Apr 4, 2025 by Equels Thomas K , who bought 2.6k USD worth of AIM shares.

Last Transactions:
Equels Thomas K
$+25.8
Rodino Peter W Iii
$+0.4
Equels Thomas K
$+67.3
Equels Thomas K
$+50.6
Equels Thomas K
$+100
Mitchell William M
$-8.9
Equels Thomas K
$+46.8
Appelrouth Stewart
$+0
Equels Thomas K
$+42.4
Appelrouth Stewart
$+158.3
Equels Thomas K
$+169.2
Equels Thomas K
$+110
Equels Thomas K
$+15.2
Equels Thomas K
$+61.6
Equels Thomas K
$+249.9
Rodino Peter W Iii
$+125.1
Bryan Nancy
$+150.2
Equels Thomas K
$+250.1
Rodino Peter W Iii
$+125.1
Appelrouth Stewart
$+300
Equels Thomas K
$+150.2
Equels Thomas K
$+100.1
Equels Thomas K
$+54.9
Equels Thomas K
$+100.1
Equels Thomas K
$+100.3
Equels Thomas K
$+500
Appelrouth Stewart
$+249.9
Rodino Peter W Iii
$+249.9
Equels Thomas K.
$+299.5
Appelrouth Stewart
$+249.1
Equels Thomas K.
$+250.9
Equels Thomas K.
$+249.4
View All Transactions

During the last 3 months AIM ImmunoTech Inc insiders have not bought any shares, and have not sold any shares. The stock price has dropped by 52% over this period (open performance analysis).

The last transaction was made on Apr 4, 2025 by Equels Thomas K , who bought 2.6k USD worth of AIM shares.

Sold
0-3
months
0 USD
0
3-6
months
0 USD
0
6-9
months
0 USD
0
9-12
months
0 USD
0
Bought
0-3
months
No Insider Transactions
0
0 USD
3-6
months
No Insider Transactions
0
0 USD
6-9
months
No Insider Transactions
0
0 USD
9-12
months
2
244.1 USD

AIM ImmunoTech Inc
Insider Trading Chart

AIM ImmunoTech Inc
Insiders Performance

1 Week Later 1 Month Later 3 Months Later 6 Months Later 1 Year Later
Average Return
Median Return
Win Rate

AIM ImmunoTech Inc
Last Insider Transactions

Global
Insiders Monitor

AIM ImmunoTech Inc
Glance View

Market Cap
3.6m USD
Industry
Biotechnology

AIM ImmunoTech, Inc. is a immuno-pharma company, which focuses on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. The company is headquartered in Ocala, Florida and currently employs 21 full-time employees. The firm is focused on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. The firm's products are Alferon N Injection and Ampligen. Alferon N Injection is a natural-source, glycosylated, multi-species alpha interferon product. Alferon is used for the treatment of refractory (resistant to other treatment) or recurring external genital warts in patients 18 years of age or older. Ampligen (rintatolimod), which is a drug of macromolecular RNA (ribonucleic acid) molecules, it is a sterile solution indicated for the treatment of severely debilitated patients with Chronic Fatigue Syndrome (CFS) who have been diagnosed for longer than one year. Ampligen is used in combination with checkpoint blockade therapies. Ampligen is also being used as a monotherapy to treat pancreatic cancer patients.

AIM Intrinsic Value
Not Available
A

What is Insider Trading?

Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.

While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.

Why is Insider Trading Important?

It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.

However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.

Peter Lynch

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

Back to Top